FDA Let Drugs Approved on Fraudulent Research Stay on the Market
In 2010, the FDA uncovered violations it later called “egregious” and “pervasive” at a major pharmaceutical testing lab. But even though the agency no longer knew for sure that drugs tested at the lab were safe, it allowed them to remain on pharmacy shelves with no new testing — in some cases until now. And the FDA won’t name the drugs.
http://www.propublica.org/article/fda-let-dru...the-market
"Stone said he expected the FDA to move swiftly to compel new testing and to publicly warn patients and doctors.
- In 2011, the FDA announced years’ worth of studies from a major drug research lab were potentially worthless.
- About 100 drugs were on the U.S. market based in part on these tests.
- The FDA let the drugs stay on pharmacy shelves with no new testing (in some cases until now).
- As the FDA investigated and ordered re-tests, its European equivalent pulled seven drugs from the market.
- The FDA says it has no evidence that any of the drugs were unsafe or that any patient has been harmed.
- The FDA has never named the drugs, saying to do so would reveal trade secrets.
In stead, the agency decided to handle the matter quietly, evaluating the medicines with virtually no public disclosure of what it had discovered. It pulled none of the drugs from the market, even temporarily, letting consumers take the ibuprofen and other medicines it no longer knew for sure were safe and effective. To this day, some drugs remain on the market despite the FDA having no additional scientific evidence to back up the safety and efficacy of these drugs."
(0)
(0)
